Should all patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy undergo epicardial catheter
Andreas Müssigbrodt1, Elena Efimova2, Helge Knopp2
1Department of Electrophysiology, Heart Centre, University of Leipzig, Strümpellstrasse 39, 04289, Leipzig, Germany. andreas.muessigbrodt@gmail.com.
Insights
An inducibility-guided approach to ventricular tachycardia (VT) ablation in arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) avoids unnecessary epicardial procedures. This strategy shows comparable long-term VT recurrence rates to combined endo- and epicardial ablation.
Area of Science:
- Cardiology
- Electrophysiology
- Medical Devices
Background:
- Epicardial radiofrequency catheter ablation is a standard treatment for arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) with recurrent ventricular tachycardia (VT).
- The study hypothesizes that VT inducibility can guide ablation strategy and influence long-term outcomes.
- Epicardial ablation was reserved for cases where VT remained inducible after endocardial ablation.
Purpose of the Study:
- To evaluate an inducibility-guided ablation approach for VT in ARVD/C patients.
- To compare long-term results of endocardial versus combined endo-epicardial ablation guided by VT inducibility.
Main Methods:
- A cohort of 45 ARVD/C patients undergoing VT ablation was analyzed from a registry.
- All patients initially underwent endocardial VT ablation.
- Epicardial ablation was performed only if VT remained inducible post-endocardial ablation.
Main Results:
- After endocardial ablation, 53.3% of patients remained inducible, prompting epicardial ablation in 48.9%.
- Overall non-inducibility was achieved in 84.4% of patients post-ablation.
- VT recurrence-free rates at mean follow-up of 31 months were similar between groups (59.1% endo-epicardial vs. 56.5% endocardial).
Conclusions:
- An inducibility-guided VT ablation strategy in ARVD/C can prevent unnecessary epicardial procedures.
- This approach offers an alternative to routine combined endo- and epicardial ablation.
- VT inducibility is a valuable factor in tailoring ablation strategies for ARVD/C patients.
Background:
Epicardial radiofrequency catheter ablation is currently considered as the therapeutic option of choice in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) and recurrent ventricular tachycardia (VT). We hypothesised that inducibility of VT may guide the ablation strategy and thereby affect long-term results. Additional epicardial ablation was only performed if VT were still inducible after thorough endocardial ablation.
Methods:
The objective was to examine an inducibility-guided ablation approach by comparing the long-term results between endocardial and epi-endocardial radiofrequency catheter ablation of VT in a large cohort of patients with ARVD/C.
Results:
We studied from our ARVD/C registry (70 patients in total, 48 males, age 53.2 ± 14.0) 45 patients (64.3% of all patients) who underwent catheter ablation of VT. All patients received endocardial VT ablation. After endocardial ablation, 24 patients (53.3%) remained inducible. Additional epicardial ablation was performed in 22 patients (48.9%). After ablation, non-inducibility was achieved in overall 38 patients (84.4%). During a mean follow-up of 31.1 ± 27.4 months, 13 patients in each group (59.1% after endo- and epicardial ablation, 56.5% after endocardial ablation) remained free from VT recurrence (P = 0.862).
Conclusions:
An inducibility-guided catheter ablation strategy of VT in patients with ARVD/C prevents unnecessary epicardial ablation and may therefore be considered as an alternative to primary combined endo- and epicardial ablation.
Related Concept Videos
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Cardiomyopathy V: Interprofessional Care
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiac Catheterization II: Right Heart Catheterization


